Biomarkers for ventilator-associated pneumonia: Review of the literature
- 1 July 2011
- journal article
- review article
- Published by Elsevier in Heart & Lung
- Vol. 40 (4) , 293-298
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K24 HL068796)
- ARCS Fellowship, Chisholm Foundation (F31 NR011390-01)
This publication has 42 references indexed in Scilit:
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-AnalysisInfection, 2009
- Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitisCritical Care, 2009
- Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumoniaIntensive Care Medicine, 2009
- Serum markers in community-acquired pneumonia and ventilator-associated pneumoniaCurrent Opinion in Infectious Diseases, 2008
- Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltratesCritical Care, 2008
- Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumoniaEuropean Respiratory Journal, 2007
- Production of Soluble Triggering Receptor Expressed on Myeloid Cells by Lipopolysaccharide-Stimulated Human Neutrophils Involves De Novo Protein SynthesisClinical and Vaccine Immunology, 2006
- C-reactive protein as a marker of infection in critically ill patientsClinical Microbiology and Infection, 2005
- Alveolar and Serum ProcalcitoninAnesthesiology, 2002